Johnson & Johnson 10Q 2012 Q1 Quarterly report | JNJ Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Accepted, ACUVUE®ADVANCE, adherence, Alex, Amneal, answer, Area, attibutable, back, Biomet, biosurgery, BYSTOLIC, cancer, castrate, certainty, chemo, Codman, concentration, contraceptive, Copeland, daily, deferral, digestive, direct, Donovan, doubtful, DURALOC, ECHELON, emotional, ENDOPATH, EPREX, estopped, feature, Field, FLEX, Florida, Forest, George, Gorsky, Greece, ground, HCI, HIV, holding, Howmedica, hypertension, immaterial, Immunology, INCIVO, incontinence, Infection, infliction, inhibitor, instability, Italy, large, Leon, mesh, metastatic, Michael, natural, nebivolol, Neuroscience, Nick, Noramco, ofloxacin, Oncology, organ, Orthopaedic, oxycodone, page, Portugal, powered, Prince, principle, proceed, prolapse, prostate, protease, Purdue, ready, reclassification, refractory, resistant, Restricted, satisfy, Shurtleff, site, situation, smoking, sodium, sovereign, Spain, Spamer, Stapler, stronger, Stryker, telaprevir, Therapeutic, Trident, Trust, urinary, waived, Wolin, Wound

Removed: Acclarent, advance, Advanced, affecting, affiliate, African, alpha, amend, American, apply, attention, Ave, Bayer, Boston, breast, CAP, category, certify, China, classify, commence, commercializing, constituted, counterpart, declaration, dedicated, deficit, defining, denial, derived, description, designing, determining, developer, discrimination, disorder, divided, DOJ, donut, Dutch, ear, East, eliminate, eliminated, eluting, employed, employment, enablement, Endeavor, Endo, enhance, equally, equitable, estimable, etravirine, exclusive, exercised, fall, gap, generation, Germany, govern, grant, Guidant, Hispanic, hole, Hong, human, HUMIRA, hyperactivity, Indonesia, INTELENCE, invalidate, iv, JJPRD, joined, JPML, Kingdom, Kong, lack, leasehold, London, managed, Medicare, Medtronic, meet, method, minimum, modified, nose, NUCYNTA, NV, objective, opposed, overturn, Pacific, People, petition, Pfizer, premier, PROCRIT, Prosecution, prospective, qualifying, recognition, recognize, Refer, Republic, repurchase, request, reserve, responded, rest, restructuring, retained, revocation, risperidone, Russia, salaried, softening, Spine, Sterilization, Stimulating, strength, submit, subsidiary, suspension, systematic, Taiwan, tapentadol, term, theIn, throat, topiramate, transdermal, Turkey, UK, uncertain, unrealized, untimely, Weldon, William, world, Wyeth, Xience

Johnson & Johnson (JNJ) 10-Q2012 Q1 Quarterly report

Content analysis